Author

S. Vasiliou

Observed names: Sylvia A. Vasiliou, Sylvia Argiroula Vasiliou, Sylvia Vasiliou, Vasiliou, S.

Observed institution: University of Liverpool

OpenAlex ID: A5047241624

Combinatorial interaction between two human serotonin transporter gene variable number tandem repeats and their regulation by CTCF

2009 · Fahad R. Ali, Sylvia A. Vasiliou, et al. · Journal of Neurochemistry · 66

PDF

Involvement of preprotachykinin A gene-encoded peptides and the neurokinin 1 receptor in endotoxin-induced murine airway inflammation

2010 · Zsuzsanna Helyes, Krisztián Elekes, et al. · Neuropeptides · 28

The SLC6A4 VNTR genotype determines transcription factor binding and epigenetic variation of this gene in response to cocaine in vitro

2011 · Sylvia A. Vasiliou, Fahad R. Ali, et al. · Addiction Biology · 27

The human neurokinin B gene, TAC3, and its promoter are regulated by Neuron Restrictive Silencing Factor (NRSF) transcription factor family

2009 · S. Gillies, K. Haddley, et al. · Neuropeptides · 26

Induction of Tachykinin Production in Airway Epithelia in Response to Viral Infection

2008 · James P. Stewart, Anja Kipar, et al. · PLoS ONE · 26

PDF

Activity-Dependent Neuroprotective Protein Modulates Its Own Gene Expression

2011 · Moutasem S. Aboonq, Sylvia A. Vasiliou, et al. · Journal of Molecular Neuroscience · 23

Chronicles in drug discovery

2010 · Cole, P., Vasiliou, S. · Drug News & Perspectives · 18

Substance P and the Tachykinins

2006 · M. R. Howard, K. Haddley, et al. · Springer eBooks · 10

Distinct Gene Expression Profiles Directed by the Isoforms of the Transcription Factor Neuron-Restrictive Silencer Factor in Human SK-N-AS Neuroblastoma Cells

2010 · Stuart G. Gillies, Kate Haddley, et al. · Journal of Molecular Neuroscience · 9

Highlights from the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)

2010 · P. Cole, S. Vasiliou · Drugs of the Future · 6

47th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2011 - Focus on first-in-human and phase I trials

2011 · S. Vasiliou, P. Cole, et al. · Drugs of the Future · 1

Lithium Chloride Regulation of the Substance P Encoding Preprotachykinin A, Tac1 Gene in Rat Hippocampal Primary Cells

2010 · Kate Haddley, Eleanor Mary Spencer, et al. · Journal of Molecular Neuroscience · 1

Medicinal chemistry Highlights from the 239th American Chemical Society National Meeting & Exposition

2010 · P. Cole, S. Vasiliou, et al. · Drugs of the Future · 1

Highlights from the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS)

2012 · S. Vasiliou · Drugs of the Future

Joint 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and 15th Conference of Rehabilitation in Multiple Sclerosis (RIMS): An update on clinical findings to improve outcomes in multiple sclerosis

2011 · S. Vasiliou · Drugs of the Future

Monographs: Azilsartan medoxomil for the treatment of hypertension.

2011 · S. Vasiliou · Dialnet (Universidad de la Rioja)

Monographs: Oral fingolimod for the treatment of relapsing-remitting multiple sclerosis.

2010 · S. Vasiliou · Dialnet (Universidad de la Rioja)

Highlights from the 39th Annual Meeting of the Society for Neuroscience

2010 · A. Arjona, E. Rosa, et al. · Drugs of the Future

Polymorphic variation modulates neurotransmitter gene expression

2008 · J. P. Quinn, K. Haddley, et al. · PsycEXTRA Dataset

Analysis of Yeast Artificial Chromosome DNA by Restriction Digestion, Southern Blotting Nucleic Acid Hybridization, and Polymerase Chain Reaction

2006 · Sylvia Vasiliou, John Peter Quinn · Humana Press eBooks

Neoadjuvant chemotherapy as a new modality of advanced pancreatic cancer treatment

2006 · Charis Kyriakides, N J Lygidakis, et al. · 日本外科学会雑誌

Works count: 21

Citation count: 242

H-index: 9

I10-index: 8